Undervalued Stocks Based on a Self-learning Algorithm: Returns up to 52.97% in 14 Days

Undervalued Stocks

The High Volume Stocks Package is designed for investors and analysts who need predictions for stocks currently trading under ten dollars, and with an average daily trading volume above one million dollars. It includes 20 stocks with bullish and bearish signals and indicates the best shares to buy and sell:

  • Low Price High Volume Stocks Top 10 stocks for the long position
  • Low Price High Volume Stocks Top 10 stocks for the short position


Package Name: Low Price High Volume Stocks
Recommended Positions: Long
Forecast Length: 14 Days (05/01/2017 – 05/15/2017)
I Know First Average: 9.65%
Undervalued Stocks

In this 14 Days forecast for the Low Price High Volume Stocks Package, there were many high performing trades and the algorithm correctly predicted 8 out 10 stocks. The top-performing prediction in this forecast was VRX, which registered a return of 52.97%. Other notable stocks were FSLR and BBD with a return of 25.85% and 7.25%. The package had an overall average return of 9.65%, providing investors with a premium of 8.89% over the S&P 500’s return of 0.76% during the same period.

Valeant Pharmaceuticals International, Inc. (VRX) develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. (VRX) was founded in 1983 and is headquartered in Laval, Canada.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.